BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8751045)

  • 1. Kinetics and metabolism of 2-chloro-2'-deoxyadenosine and 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine in the isolated perfused rat liver.
    Albertioni F; Hassan M; Silberring J; Liliemark J
    Eur J Drug Metab Pharmacokinet; 1995; 20(3):225-32. PubMed ID: 8751045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability and analysis of 2-chloro-2'-deoxyadenosine, 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine and 2-chloroadenine in human blood plasma.
    Lindemalm S; Albertioni F; Liliemark J
    Anticancer Drugs; 1997 Jun; 8(5):445-53. PubMed ID: 9215606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, a novel analogue of cladribine in human leukemic cells.
    Lotfi K; Månsson E; Spasokoukotskaja T; Pettersson B; Liliemark J; Peterson C; Eriksson S; Albertioni F
    Clin Cancer Res; 1999 Sep; 5(9):2438-44. PubMed ID: 10499616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cytotoxicity of 2-chloro- 2'-arabino-fluoro-2'-deoxyadenosine (clofarabine) with cladribine in mononuclear cells from patients with acute myeloid and chronic lymphocytic leukemia.
    Lindemalm S; Liliemark J; Gruber A; Eriksson S; Karlsson MO; Wang Y; Albertioni F
    Haematologica; 2003 Mar; 88(3):324-32. PubMed ID: 12651272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of 2-chloro-2'-deoxyadenosine, 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, fludarabine and cytarabine in mice: a whole-body autoradiography study.
    Lindemalm S; Liliemark J; Larsson BS; Albertioni F
    Med Oncol; 1999 Dec; 16(4):239-44. PubMed ID: 10618686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance.
    Månsson E; Flordal E; Liliemark J; Spasokoukotskaja T; Elford H; Lagercrantz S; Eriksson S; Albertioni F
    Biochem Pharmacol; 2003 Jan; 65(2):237-47. PubMed ID: 12504799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine.
    Carson DA; Wasson DB; Esparza LM; Carrera CJ; Kipps TJ; Cottam HB
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2970-4. PubMed ID: 1348362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and cytotoxic effects of 2-chloroadenine, the major catabolite of 2-chloro-2'-deoxyadenosine.
    Bontemps F; Delacauw A; Cardoen S; Van Den Neste E; Van Den Berghe G
    Biochem Pharmacol; 2000 May; 59(10):1237-43. PubMed ID: 10736424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of DNA methylation of the 5' region of the deoxycytidine kinase gene in CCRF-CEM-sensitive and cladribine (CdA)- and 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine (CAFdA)-resistant cells.
    Leegwater PA; De Abreu RA; Albertioni F
    Cancer Lett; 1998 Aug; 130(1-2):169-73. PubMed ID: 9751270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability and bacterial degradation of rectally administered 2-chloro-2'-deoxyadenosine.
    Liliemark J; Albertioni F; Edlund C; Juliusson G
    J Pharm Biomed Anal; 1995 Apr; 13(4-5):661-5. PubMed ID: 9696584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Chloro-2'-deoxyadenosine--clinical, biochemical and pharmacokinetic considerations.
    Liliemark J; Juliusson G
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):7-10. PubMed ID: 7503639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interspecies differences in the kinetic properties of deoxycytidine kinase elucidate the poor utility of a phase I pharmacologically directed dose-escalation concept for 2-chloro-2'-deoxyadenosine.
    Reichelová V; Juliusson G; Spasokoukotskaja T; Eriksson S; Liliemark J
    Cancer Chemother Pharmacol; 1995; 36(6):524-9. PubMed ID: 7554045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel leukemic cell lines resistant to clofarabine by mechanisms of decreased active metabolite and increased antiapoptosis.
    Shigemi H; Yamauchi T; Tanaka Y; Ueda T
    Cancer Sci; 2013 Jun; 104(6):732-9. PubMed ID: 23421409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between cladribine (CdA) plasma, intracellular CdA-5'-triphosphate (CdATP) concentration, deoxycytidine kinase (dCK), and chemotherapeutic activity in chronic lymphocytic leukemia (CLL).
    Albertioni F; Lindemalm S; Eriksson S; Juliusson G; Liliemark J
    Adv Exp Med Biol; 1998; 431():693-7. PubMed ID: 9598154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.
    Cardoen S; Van Den Neste E; Smal C; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
    Clin Cancer Res; 2001 Nov; 7(11):3559-66. PubMed ID: 11705877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid chromatographic study of acid stability of 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, 2-chloro-2'-deoxyadenosine and related analogues.
    Reichelova V; Liliemark J; Albertioni F
    J Pharm Biomed Anal; 1995 Apr; 13(4-5):711-4. PubMed ID: 9696594
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the in vitro and in vivo metabolism of Cladribine (Leustatin, Movectro) in animals and human.
    Scheible H; Laisney M; Wimmer E; Javornik A; Dolgos H
    Xenobiotica; 2013 Dec; 43(12):1084-94. PubMed ID: 23627543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and elimination of 5,6-dimethylxanthenone-4-acetic acid in the isolated perfused rat liver.
    Webster LK; Ellis AG; Kestell P; Rewcastle GW
    Drug Metab Dispos; 1995 Mar; 23(3):363-8. PubMed ID: 7628302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line.
    Månsson E; Spasokoukotskaja T; Sällström J; Eriksson S; Albertioni F
    Cancer Res; 1999 Dec; 59(23):5956-63. PubMed ID: 10606241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Chloro-2'-deoxyadenosine inhibits DNA repair synthesis and potentiates UVC cytotoxicity in chronic lymphocytic leukemia B lymphocytes.
    Van Den Neste E; Cardoen S; Husson B; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
    Leukemia; 2002 Jan; 16(1):36-43. PubMed ID: 11840261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.